Literature DB >> 22044600

MALDI-TOF MS Andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures.

E Bille1, B Dauphin, J Leto, M-E Bougnoux, J-L Beretti, A Lotz, S Suarez, J Meyer, O Join-Lambert, P Descamps, N Grall, F Mory, L Dubreuil, P Berche, X Nassif, A Ferroni.   

Abstract

All organisms usually isolated in our laboratory are now routinely identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) using the Andromas software. The aim of this study was to describe the use of this strategy in a routine clinical microbiology laboratory. The microorganisms identified included bacteria, mycobacteria, yeasts and Aspergillus spp. isolated on solid media or extracted directly from blood cultures. MALDI-TOF MS was performed on 2665 bacteria isolated on solid media, corresponding to all bacteria isolated during this period except Escherichia coli grown on chromogenic media. All acquisitions were performed without extraction. After a single acquisition, 93.1% of bacteria grown on solid media were correctly identified. When the first acquisition was not contributory, a second acquisition was performed either the same day or the next day. After two acquisitions, the rate of bacteria identified increased to 99.2%. The failures reported on 21 strains were due to an unknown profile attributed to new species (9) or an insufficient quality of the spectrum (12). MALDI-TOF MS has been applied to 162 positive blood cultures. The identification rate was 91.4%. All mycobacteria isolated during this period (22) were correctly identified by MALDI-TOF MS without any extraction. For 96.3% and 92.2% of yeasts and Aspergillus spp., respectively, the identification was obtained with a single acquisition. After a second acquisition, the overall identification rate was 98.8% for yeasts (160/162) and 98.4% (63/64) for Aspergillus spp. In conclusion, the MALDI-TOF MS strategy used in this work allows a rapid and efficient identification of all microorganisms isolated routinely.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Year:  2011        PMID: 22044600     DOI: 10.1111/j.1469-0691.2011.03688.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  40 in total

Review 1.  Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories.

Authors:  Alex van Belkum; Martin Welker; Marcel Erhard; Sonia Chatellier
Journal:  J Clin Microbiol       Date:  2012-02-22       Impact factor: 5.948

2.  The influence of different pH on the electrophoretic behaviour of Saccharomyces cerevisiae modified by calcium ions.

Authors:  Agnieszka Rogowska; Paweł Pomastowski; Michał Złoch; Viorica Railean-Plugaru; Anna Król; Katarzyna Rafińska; Małgorzata Szultka-Młyńska; Bogusław Buszewski
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

3.  Performances of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for rapid identification of bacteria in routine clinical microbiology.

Authors:  Damien Dubois; Marion Grare; Marie-Françoise Prere; Christine Segonds; Nicole Marty; Eric Oswald
Journal:  J Clin Microbiol       Date:  2012-05-16       Impact factor: 5.948

Review 4.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology.

Authors:  Andrew E Clark; Erin J Kaleta; Amit Arora; Donna M Wolk
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

5.  Misidentification of Aspergillus nomius and Aspergillus tamarii as Aspergillus flavus: characterization by internal transcribed spacer, β-Tubulin, and calmodulin gene sequencing, metabolic fingerprinting, and matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Emily W T Tam; Jonathan H K Chen; Eunice C L Lau; Antonio H Y Ngan; Kitty S C Fung; Kim-Chung Lee; Ching-Wan Lam; Kwok-Yung Yuen; Susanna K P Lau; Patrick C Y Woo
Journal:  J Clin Microbiol       Date:  2014-01-22       Impact factor: 5.948

6.  Phylogeny, identification and nomenclature of the genus Aspergillus.

Authors:  R A Samson; C M Visagie; J Houbraken; S-B Hong; V Hubka; C H W Klaassen; G Perrone; K A Seifert; A Susca; J B Tanney; J Varga; S Kocsubé; G Szigeti; T Yaguchi; J C Frisvad
Journal:  Stud Mycol       Date:  2014-06       Impact factor: 16.097

7.  Advantages of using matrix-assisted laser desorption ionization-time of flight mass spectrometry as a rapid diagnostic tool for identification of yeasts and mycobacteria in the clinical microbiological laboratory.

Authors:  Jonathan H K Chen; Wing-Cheong Yam; Antonio H Y Ngan; Ami M Y Fung; Wai-Lan Woo; Mei-Kum Yan; Garnet K Y Choi; Pak-Leung Ho; Vincent C C Cheng; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

8.  Development and validation of an in-house database for matrix-assisted laser desorption ionization-time of flight mass spectrometry-based yeast identification using a fast protein extraction procedure.

Authors:  Elena De Carolis; Antonietta Vella; Luisa Vaccaro; Riccardo Torelli; Patrizia Posteraro; Walter Ricciardi; Maurizio Sanguinetti; Brunella Posteraro
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

9.  Bacterial classification of fish-pathogenic Mycobacterium species by multigene phylogenetic analyses and MALDI Biotyper identification system.

Authors:  Satoru Kurokawa; Jun Kabayama; Tsuguaki Fukuyasu; Seong Don Hwang; Chan-Il Park; Seong-Bin Park; Carmelo S del Castillo; Jun-ichi Hikima; Tae-Sung Jung; Hidehiro Kondo; Ikuo Hirono; Haruko Takeyama; Takashi Aoki
Journal:  Mar Biotechnol (NY)       Date:  2012-11-16       Impact factor: 3.619

Review 10.  Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species.

Authors:  Anna Dudakova; Birgit Spiess; Marut Tangwattanachuleeporn; Christoph Sasse; Dieter Buchheidt; Michael Weig; Uwe Groß; Oliver Bader
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.